Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
30 participants
OBSERVATIONAL
2011-03-31
2016-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Somatic Stem Cells in Leiomyomas?
NCT01592903
Endometriosis Transcriptomic Cell Atlas
NCT06502548
ENDOMET - Novel Diagnostic Tools and Treatments for Endometriosis
NCT01301885
The Developmental Origins of Endometriosis
NCT05951452
Bone Marrow Cell Engraftment of the Uterus and Genetic Studies of Reproductive Functioning
NCT01468935
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Endometriosis is an estrogen-dependent chronic disease characterized by the presence of functional endometrium outside the uterine cavity, mainly in the peritoneum and ovary (Giudice and Kao, 2004). It affects 6-10% of women of reproductive age, often resulting in a series of gynecological problems, including dysmenorrhea, pelvic pain and infertility. The nature of endometriosis suggests that the initiation of ectopic endometrial lesions may be due to stem or progenitor cells, which is consistent with the theory of retrograde menstruation (Starzinski-Powitz et al. 2001; Leyendecker et al. 2002, Gargett, 2006; Gargett, 2007, Sasson and Taylor, 2008). To date, no direct evidence of the role of somatic stem cells of the endometrium in the pathogenesis of endometriosis. However, numerous studies show that ectopic endometrial cells implant in many established models used for the study of endometriosis.(Masuda et al., 2007b; Sasson and Taylor, 2008; Gargett y Masuda.,2010)
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
ARM 1
ENDOMETRIAL SAMPLE
genetic analysis
1. To identify by flow cytometry through technique of "Side Population" the population of somatic stem cells present in both human endometrial eutopic and ectopic endometrium of women with ovarian endometriosis, peritoneal and recto-vaginal.
2. In vitro culture conditions for cell proliferation.
3. To characterize the somatic stem cell population using techniques of endometriotic cell and molecular biology.
4. Compare the results obtained from patients with endometriosis with control patients (without endometriosis) earlier work by our group.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
genetic analysis
1. To identify by flow cytometry through technique of "Side Population" the population of somatic stem cells present in both human endometrial eutopic and ectopic endometrium of women with ovarian endometriosis, peritoneal and recto-vaginal.
2. In vitro culture conditions for cell proliferation.
3. To characterize the somatic stem cell population using techniques of endometriotic cell and molecular biology.
4. Compare the results obtained from patients with endometriosis with control patients (without endometriosis) earlier work by our group.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Aged between 20 and 40.
3. Signing of informed consent for collection and storage of biological samples.
Exclusion Criteria
2. Failure to sign informed consent for collection and storage of biological samples.
20 Years
40 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Igenomix
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Carlos Simon
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Carlos Simon, MDPhd
Role: PRINCIPAL_INVESTIGATOR
IVI Valencia
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
IVI Valencia
Valencia, , Spain
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1006-C-073-CS-F
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.